HighVista Strategies »

Bausch Health Companies shares owned by HighVista Strategies

Quarter-by-quarter ownership of Bausch Health Companies (BHC) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Bausch Health Companies

Tip: Access up to 7 years of quarterly data

All positions including Bausch Health Companies held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bausch Health Companies by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.0M 218k 9.33
2023-06-30 $787k 98k 8.00

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding Bausch Health Companies

Paulson & Co
GoldenTree Asset Management
Nomura Holdings
Healthcare Of Ontario Pension Plan Trust Fund
Vanguard Group
Royal Bank of Canada
National Bank Of Canada /fi/
MFN Partners Management
Kohlberg Kravis Roberts & Co
ING Groep
Hudson Bay Capital Management
Mitsubishi UFJ Securities International
Macquarie Group
Goldman Sachs Group
Dimensional Fund Advisors

View all funds holding Bausch Health Companies